By Josh Beckerman
Shares of Inspire Medical Systems closed the regular session higher after the Centers for Medicare and Medicaid Services issued a reimbursement update.
The stock gained 15%, to $68.05, Thursday. It has fallen about 65% over the past 12 months.
CMS said it is adding six new codes for hypoglossal nerve stimulators in the April 2026 Integrated Outpatient Code Editor, effective Jan. 1, 2026, according to KeyBanc Capital Markets, which called the development "directionally positive."
Meanwhile, Baird said the update limits "some of the reimbursement challenges that have weighed on" Inspire and Nyxoah. During the regular session, Nyxoah shares rose 5.6%, to $4.70.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
February 26, 2026 18:27 ET (23:27 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments